Phi Therapeutics, Inc. — Form D/A

Phi Therapeutics, Inc. of PETALUMA, CA, a company, filed a Form D amendment with the SEC on 2024-06-26. The offering totals $7.7M, of which $7.7M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2024-06-26
• Form: D/A
• Accession: 0001778492-24-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $7.7M
• Amount sold: $7.7M
• Minimum investment: $10K
• Investors: 22
• Date of first sale: 2023-03-22
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-478065

Issuer

• Name: Phi Therapeutics, Inc.
• CIK: 0001778492
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 1250 PETALUMA BLVD N, PETALUMA, CA, 94952
• Phone: 707-243-8820

Officers, directors & promoters (12)

Other filings by this issuer (3)

More

• CIK 1778492 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search